IL10 and rheumatoid arthritis: Functional defects in RA Tregs include decreased production of IL‐10 and TGFβ, along with abnormalities in CTLA4 and the IL‐2 receptor CD25, which collectively compromise their ability to suppress effector T cell activity [107, 108].